Clinical Trial Update: O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of O6-benzylguanine and carmustine in patients with recurrent, metastatic, or locally advanced soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• BiCNU (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: University of Chicago | Conditions: Sarcoma | Phase 2 | Status: COMPLETED